Factores de riesgo asociados a complicaciones perioperatorias en la resección transuretral de próstata con bipolar. Revisión narrativa de la literatura

Lesly Roxana Suaza-Martínez, Jenny García-Valencia, Alina María Giraldo-Arismendi

Resumen


Introducción: la resección transuretral de próstata (RTUP), independiente de si es con equipo monopolar o bipolar (RTUP-B), es la cirugía estándar en el manejo quirúrgico de los síntomas del tracto urinario inferior (STUI) o de las complicaciones derivadas de la obstrucción por hiperplasia prostática benigna (HPB).

Objetivo: revisar la literatura sobre frecuencia y factores de riesgo para complicaciones de la RTUP con bipolar.

Resultados: se hizo una revisión de la literatura mediante la búsqueda en Medline desde 1996 hasta 2017. De 76 artículos revisados, 50 se incluyeron. Estos reportan que la RTUP-B ofrece buenos resultados a largo plazo. Las complicaciones en su mayoría son grado I según la clasificación de Clavien-Dindo y las más frecuentes son la eyaculación retrógrada, hematuria secundaria, retención o infección urinaria y estrechez uretral o contractura del cuello vesical. Los factores de riesgo fueron comorbilidades, gravedad de la enfermedad al momento de la intervención, técnica y habilidad del cirujano, entre otros.

Discusión: aunque la mayoría de las complicaciones secundarias a la RTUP-B son leves, definir el momento óptimo para la realización de la cirugía e intervenir los factores de riesgo modificables, podría contribuir a mejorar los resultados de esta técnica quirúrgica. 


Palabras clave


Complicaciones Intraoperatorias; Complicaciones Posoperatorias; Resección Transuretral de la Próstata

Texto completo:

PDF XHTML

Referencias


(1.) Vuichoud C, Loughlin KR. Benign prostatic hyperplasia: epidemiology, economics and evaluation. Can J Urol. 2015 Oct;22 Suppl 1:1-6.

(2.) Ramos HL, Cusnir PG, Moreno M, Patiño G, Rasch-Isla A, Dallos A, et al. Guía de manejo de la hiperplasia prostática benigna. Sociedad Colombiana de Urología 2014. Urol Colomb. 2015;24(3):187.e1-187. e32. https://doi.org/10.1016/j.uroco.2015.04.005

(3.) Mandeville J, Mourtzinos A. Surgical Management of Male Voiding Dysfunction. Surg Clin North Am. 2016 Jun;96(3):491-501. DOI 10.1016/j.suc.2016.02.006.

(4.) Woodard TJ, Manigault KR, McBurrows NN, Wray TL, Woodard LM. Management of Benign Prostatic Hyperplasia in Older Adults. Consult Pharm. 2016;31(8):412-24. DOI 10.4140/TCP.n.2016.412.

(5.) Kawamura Y, Tokunaga M, Hoshino H, Matsushita K, Terachi T. Clinical Outcomes of Transurethral Enucleation with Bipolar for Benign Prostatic Hypertrophy. Tokai J Exp Clin Med. 2015 Dec;40(4):132-6.

(6.) Yang EJ, Li H, Sun XB, Huang L, Wang L, Gong XX, et al. Bipolar versus monopolar transurethral resection of the prostate for benign prostatic hyperplasia: safe in patients with high surgical risk. Sci Rep. 2016 Feb;6:21494. DOI 10.1038/srep21494.

(7.) Blankstein U, Van Asseldonk B, Elterman DS. BPH update: medical versus interventional management. Can J Urol. 2016 Feb;23(Suppl 1):10-5.

(8.) Hadi N, Aminsharifi A, Sadeghi A, Tourchi A. Superselective α-adrenergic blockers versus transurethral resection of the prostate: a prospective comparison of health-related quality of life outcome after treating patients with benign prostatic hyperplasia. Qual Life Res. 2013 Aug;22(6):1287-93. DOI 10.1007/s11136-012-0259-7.

(9.) Macey MR, Raynor MC. Medical and Surgical Treatment Modalities for Lower Urinary Tract Symptoms in the Male Patient Secondary to Benign Prostatic Hyperplasia: A Review. Semin Intervent Radiol. 2016 Sep;33(3):217-23. DOI 10.1055/s-0036-1586142.

(10.) Mayer EK, Kroeze SG, Chopra S, Bottle A, Patel A. Examining the ‘gold standard’: a comparative critical analysis of three consecutive decades of monopolar transurethral resection of the prostate (TURP) outcomes. BJU Int. 2012 Dec;110(11):1595-601. DOI 10.1111/j.1464-410X.2012.11119.x.

(11.) Thomas JA, Tubaro A, Barber N, d’Ancona F, Muir G, Witzsch U, et al. A Multicenter Randomized Noninferiority Trial Comparing GreenLight-XPS Laser Vaporization of the Prostate and Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Obstruction: Two-yr Outcomes of the GOLIATH Study. Eur Urol. 2016 Jan;69(1):94-102. DOI 10.1016/j.eururo. 2015.07.054.

(12.) Volpe A, Billia M, Quaglia M, Vidali M, Marchioro G, Ceratti G, et al. Transurethral resection of the prostate in kidney transplant recipients: urological and renal functional outcomes at long-term follow-up. BJU Int. 2013 Aug;112(3):386-93. DOI 10.1111/bju.12030.

(13.) brams P, Chapple C, Khoury S, Roehrborn C, de la Rosette J; International Consultation on New Developments in Prostate Cancer and Prostate Diseases. Evaluation and treatment of lower urinary tract symptoms in older men. J Urol. 2013 Jan;189(1 Suppl):S93-S101. DOI 10.1016/j.juro.2012.11.021.

(14.) Li X, Pan JH, Liu QG, He P, Song SJ, Jiang T, et al. Selective transurethral resection of the prostate combined with transurethral incision of the bladder neck for bladder outlet obstruction in patients with small volume benign prostate hyperplasia (BPH): a prospective randomized study. PLoS One. 2013 May;8(5):e63227. DOI 10.1371/journal.pone.0063227.

(15.) Pinheiro LC, Martins Pisco J. Treatment of benign prostatic hyperplasia. Tech Vasc Interv Radiol. 2012 Dec;15(4):256-60. DOI 10.1053/j.tvir.2012.09.004.

(16.) Cornu JN, Ahyai S, Bachmann A, de la Rosette J, Gilling P, Gratzke C, et al. A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Obstruction: An Update. Eur Urol. 2015 Jun;67(6):1066-96. DOI 10.1016/j.eururo.2014.06.017.

(17.) Mitropoulos D, Artibani W, Biyani CS, Bjerggaard Jensen J, Rouprêt M, Truss M. Validation of the Clavien-Dindo Grading System in Urology by the European Association of Urology Guidelines Ad Hoc Panel. Eur Urol Focus. 2018 Jul;4(4):608-13. DOI 10.1016/j.euf.2017.02.014.

(18.) Mandal S, Sankhwar SN, Kathpalia R, Singh MK, Kumar M, Goel A, et al. Grading complications after transurethral resection of prostate using modified Clavien classification system and predicting complications using the Charlson comorbidity index. Int Urol Nephrol. 2013 Apr;45(2):347-54. DOI 10.1007/s11255-013-0399-x.

(19.) Smith C, Craig P, Taleb S, Young S, Golzarian J. Comparison of Traditional and Emerging Surgical Therapies for Lower Urinary Tract Symptoms in Men: A Review. Cardiovasc Intervent Radiol. 2017 Aug;40(8):1176-84. DOI 10.1007/s00270-017-1575-7.

(20.) McGowan-Smyth S, Vasdev N, Gowrie-Mohan S. Spinal Anesthesia Facilitates the Early Recognition of TUR Syndrome. Curr Urol. 2016 May;9(2):57-61. DOI 10.1159/000442854.

(21.) Neyer M, Reissigl A, Schwab C, Pointner J, Abt D, Bachmayer C, et al. Bipolar versus monopolar transurethral resection of the prostate: results of a comparative, prospective bicenter study--perioperative outcome and long-term efficacy. Urol Int. 2013;90(1):62-7. DOI 10.1159/000343688.

(22.) Rieken M, Bachmann A, Shariat SF. Long-term follow-up data more than 5 years after surgical management of benign prostate obstruction: who stands the test of time? Curr Opin Urol. 2016 Jan;26(1):22-7. DOI 10.1097/MOU.0000000000000244.

(23.) da Silva RD, Bidikov L, Michaels W, Gustafson D, Molina WR, Kim FJ. Bipolar energy in the treatment of benign prostatic hyperplasia: a current systematic review of the literature. Can J Urol. 2015 Oct;22 Suppl 1:30-44.

(24.) Omar MI, Lam TB, Alexander CE, Graham J, Mamoulakis C, Imamura M, et al. Systematic review and meta-analysis of the clinical effectiveness of bipolar compared with monopolar transurethral resection of the prostate (TURP). BJU Int. 2014 Jan;113(1):24-35. DOI 10.1111/bju.12281.

(25.) Yee CH, Wong JH, Chiu PK, Teoh JY, Chan CK, Chan ES, et al. Secondary hemorrhage after bipolar transurethral resection and vaporization of prostate. Urol Ann. 2016 Oct-Dec;8(4):458-63. DOI 10.4103/0974-7796.192110.

(26.) Elkoushy MA, Luz MA, Benidir T, Aldousari S, Aprikian AG, Andonian S. Clavien classification in urology: Is there concordance among post-graduate trainees and attending urologists? Can Urol Assoc J. 2013 May-Jun;7(5-6):179-84. DOI 10.5489/cuaj.505.

(27.) Taylor BL, Jaffe WI. Electrosurgical transurethral resection of the prostate and transurethral incision of the prostate (monopolar techniques). Can J Urol. 2015 Oct;22 Suppl 1:24-9.

(28.) Cornu JN. Bipolar, Monopolar, Photovaporization of the Prostate, or Holmium Laser Enucleation of the Prostate: How to Choose What’s Best? Urol Clin North Am. 2016 Aug;43(3):377-84. DOI 10.1016/j.ucl.2016.04.006.

(29.) Guo RQ, Yu W, Meng YS, Zhang K, Xu B, Xiao YX, et al. Correlation of benign prostatic obstruction-related complications with clinical outcomes in patients after transurethral resection of the prostate. Kaohsiung J Med Sci. 2017 Mar;33(3):144-51. DOI 10.1016/j.kjms.2017.01.002.

(30.) Heidler S, Bretterbauer K, Schwarz S, Albrecht W. Diversity of Bacterial Urine and Prostate Gland Tissue Cultures in Patients Undergoing Transurethral Prostate Gland Resection. Urol Int. 2016;97(3):336-9.

(31.) Yee CH, Wong JH, Chiu PK, Chan CK, Lee WM, Tsu JH, et al. Short-stay transurethral prostate surgery: A randomized controlled trial comparing transurethral resection in saline bipolar transurethral vaporization of the prostate with monopolar transurethral resection. Asian J Endosc Surg. 2015 Aug;8(3):316-22. DOI 10.1111/ases.12197.

(32.) Uchida T, Ohori M, Soh S, Sato T, Iwamura M, Ao T, et al. Factors influencing morbidity in patients undergoing transurethral resection of the prostate. Urology [Internet]. 1999 Jan;53(1):98-104. Available from: http://www.sciencedirect.com/science/article/pii/S009042959800524X

(33.) Elshal AM, Elmansy HM, Elhilali MM. Transurethral laser surgery for benign prostate hyperplasia in octogenarians: safety and outcomes. Urology. 2013 Mar;81(3):634-9. DOI 10.1016/j.urology.2012.11.042.

(34.) Matani Y, Mottrie AM, Stöckle M, Voges GE, Fichtner J, Hohenfellner R. Transurethral prostatectomy: a longterm follow-up study of 166 patients over 80 years of age. Eur Urol. 1996;30(4):414-7.

(35.) Schoevaerdts D, Swine C, Verroken A, Huang TD, Glupczynski Y. Asymptomatic colonization by Clostridium difficile in older adults admitted to a geriatric unit: a prospective cohort study. J Am Geriatr Soc. 2011 Nov;59(11):2179-81. DOI 10.1111/j.1532-5415.2011.03685.x.

(36.) Losco G, Mark S, Jowitt S. Transurethral prostate resection for urinary retention: does age affect outcome? ANZ J Surg. 2013 Apr;83(4):243-5. DOI 10.1111/ans.12014.

(37.) Allard CB, Meyer CP, Gandaglia G, Chang SL, Chun FK, Gelpi-Hammerschmidt F, et al. The Effect of Resident Involvement on Perioperative Outcomes in Transurethral Urologic Surgeries. J Surg Educ. 2015 Sep-Oct;72(5):1018-25. DOI 10.1016/j.jsurg.2015.04.012.

(38.) Aminsharifi A, Salehi A, Noorafshan A, Aminsharifi A, Alnajar K. Effect of Preoperative Finasteride on the Volume or Length Density of Prostate Vessels, Intraoperative, Postoperative Blood Loss during and after Monopolar Transurethral Resection of Prostate: A Dose Escalation Randomized Clinical Trial Using Stereolog Methods. Urol J. 2016 Mar 5;13(1):2562-8.

(39.) Pastore AL, Mariani S, Barrese F, Palleschi G, Valentini AM, Pacini L, et al. Transurethral resection of prostate and the role of pharmacological treatment with dutasteride in decreasing surgical blood loss. J Endourol. 2013 Jan;27(1):68-70. DOI 10.1089/end.2012.0231.

(40.) Virseda-Rodríguez AJ, Padilla-Fernández B, López-Parra M, Santos-Antunes MT, Valverde-Martínez LS, Nieto-González MJ, et al. Influence of antiplatelet-anticoagulant drugs on the need of blood components transfusion after vesical transurethral resection. Arch Ital Urol Androl. 2015 Jul;87(2):136-40. DOI 10.4081/aiua.2015.2.136.

(41.) Descazeaud A, Robert G, Lebdai S, Bougault A, Azzousi AR, Haillot O, et al. Impact of oral anticoagulation on morbidity of transurethral resection of the prostate. World J Urol. 2011 Apr;29(2):211-6. DOI 10.1007/s00345-010-0561-3.

(42.) Vincent DP. Bladder explosion during transurethral resection of prostate: Bladder diverticula as an additional risk factor. Urol Ann. 2017 Jan-Mar;9(1):68-70. DOI 10.4103/0974-7796.198887.

(43.) Parker DC, Simhan J. Management of complications after surgical outlet reduction for benign prostatic obstruction. Can J Urol. 2015 Oct;22 Suppl 1:88-92.

(44.) Liu CC, Huang SP, Chou YH, Wang CJ, Huang CH. Current indications for transurethral resection of the prostate and associated complications. Kaohsiung JMed Sci. 2003 Feb;19(2):49-54.

(45.) Tubaro A. Editorial comment: Acute urinary retention increases the risk of complications after transurethral resection of the prostate: a population-based study. BJU Int. 2012 Dec;110(11 Pt C):E902. DOI 10.1111/j.1464-410X.2012.11486.x.

(46.) Cruz Arévalo A, Cárdenas AM, Gómez JE, Reyes JC, Duarte RA. Factores predictores de complicaciones infecciosas en pacientes sometidos a prostatectomía. Urol Colomb. 2017 May-Ago;26(2):77-152. DOI 10.1016/j.uroco.2016.06.003.

(47.) Marra G, Sturch P, Oderda M, Tabatabaei S, Muir G, Gontero P. Systematic review of lower urinary tract symptoms/benign prostatic hyperplasia surgical treatments on men’s ejaculatory function: Time for a bespoke approach? Int J Urol. 2016 Jan;23(1):22-35. DOI 10.1111/iju.12866.

(48.) Yu H, Wu H, Rao D. Analysis of the therapeutic effect of tadalafil on male ED after transurethral resection of prostate. Int J Impot Res. 2012 Jul-Aug;24(4):147-9. DOI 10.1038/ijir.2012.6.

(49.) Tang Y, Li J, Pu C, Bai Y, Yuan H, Wei Q, et al. Bipolar transurethral resection versus monopolar transurethral resection for benign prostatic hypertrophy: a systematic review and meta-analysis. J Endourol. 2014 Sep;28(9):1107-14. DOI 10.1089/end.2014.0188.

(50.) Palaniappan S, Kuo TL, Cheng CW, Foo KT. Early outcome of transurethral enucleation and resection of the prostate versus transurethral resection of the prostate. Singapore Med J. 2016 Dec;57(12):676-80. DOI 10.11622/smedj.2016026.




DOI: https://doi.org/10.17533/udea.iatreia.06 Resumen : 332 PDF : 181 XHTML : 0

Métricas de artículo

Cargando métricas ...

Metrics powered by PLOS ALM


Copyright (c) 2019 Iatreia

Licencia de Creative Commons
Este obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial-SinObraDerivada 4.0 Internacional.

Esta publicación hace parte del Sistema de Revistas de la Universidad de Antioquia
¿Quieres aprender a usar el Open Journal system? Ingresa al Curso virtual
Este sistema es administrado por el Programa Integración de Tecnologías a la Docencia
Universidad de Antioquia
Powered by Public Knowledge Project